Digital Pathology Market worth US$ 3.8 Billion 2034 with a CAGR of 13.6%

Growing used of digital pathology by large biopharmaceuticals and top clinical research organizations (CROs) to modernize drug development processes in discovery, pre-clinical and clinical trials such factor driving the growth for the target market. Additionally, it is an innovation dedicated to the reduction of laboratory expenses, an improvement of operational efficiency, enhanced productivity, and improving treatment decisions and patient care such factor boosting the growth for the target market.Digital pathology Market was valued at US$ 1.2 billion in 2024 and is projected to grow at a CAGR of 13.6% to reach US$ 3.8 billion by 2034.

The report "Digital Pathology Market by Application (Disease Diagnosis, Drug Discovery, Teleconsultation), By Product (Scanner, Software, Communication System), By Type (Human, Veterinary), By End User (Pharmaceutical & Biotechnology Companies), and Region - Global Forecast to 2034"

. Key Highlights:

• August, 9^th 2019. Leica Biosystems, the global leader in pathology workflow solutions, announced to launch the Aperio GT 450, its next-generation digital pathology scanner.
• December, 21^st 2017 Leica Biosystems Deal to Advance Artificial Intelligence in Pathology as part of UK Life Sciences Sector. This agreement draws substantial investment into the sector including the development of a trail-blazing digital pathology program leveraging Artificial Intelligence (AI).

Key Market Insights from the report:          

Digital pathology market accounted for US$ 1.2 billion in 2024 and is projected to register a moderate CAGR of 13.6% over the forecast period. The market report has been segmented based on application, product, type and end-users and region.

• By Application global digital pathology market is classified into disease diagnosis, drug discovery, teleconsultation.
• By Product global digital pathology market is classified into the scanner, software, communication system.
• By Type global digital pathology market is classified into human, veterinary
• By End-user global digital pathology market is classified into Pharmaceutical & Biotechnology Companies
• By Region, North America dominates the market. Owing to continuous R&D investments, supportive government initiatives are the factor driving the growth for the target market. Asia Pacific is expected to show the highest CAGR during the forecast period. Because of the rising penetration of digital imaging, growing investments in the medical field are some factor drives regional growth. Additionally increased incidence of cancer support the growing regional market.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Digital Pathology Market by Application (Disease Diagnosis, Drug Discovery, Teleconsultation), By Product (Scanner, Software, Communication System), By Type (Human, Veterinary), By End User (Pharmaceutical & Biotechnology Companies), and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) - forecast till 2034"

The key players operating the global Digital Pathology market involves 3DHistech Ltd., Definiens AG, Hamamatsu Photonics K.K., Leica Biosystems Nussloch GmBH, Mikroscan Technologies Inc., Nikon Corporation, Olympus Corporation, Koninklijke Philips NV, Ventana Medical Systems Inc.and VISIONPHARM. The key players in the market are focusing on partnership and merger acquisition strategy.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing and business strategy, and solutions company development company which offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. Also, we help our client to address business challenges and provide the best possible solutions to overcome them and transform their business. 

To know more

Contact Us:

Sales

Prophecy Market Insights

U.S: 1 860 531 2574

RoW: 91 7775049802

Email- [email protected]

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com